A novel M1 PAM VU0486846 exerts efficacy in cognition models without displaying agonist activity or cholinergic toxicity

4 Likes

Do you know if this is the same Vanderbilt University drug they are working on with Lundbeck, or another?

1 Like

Yes i think they are the same… its mostly treats cognitive symptoms… nothing new about negative symptoms…!!!

Your search - “VU0486846” schizophrenia “lundbeck” - did not match any documents.

https://www.google.com/search?client=firefox-b&biw=1150&bih=611&ei=kfflWtqsEsvfgAbW97DAAg&q="VU0486846"+schizophrenia+"lundbeck"&oq="VU0486846"+schizophrenia+"lundbeck"&gs_l=psy-ab.12...67008.76708.0.79678.11.11.0.0.0.0.148.1382.0j11.11.0…0…1.1.64.psy-ab…0.2.250…33i21k1.0.33VeixoKIfQ

1 Like